Cole Lannum | Senior Vice President of Investor Relations, IRO |
Bryan Hanson | President and CEO |
Dan Florin | Chief Financial Officer |
Mike Mattson | Needham & Company |
Bruce Nudell | SunTrust |
Chris Pasquale | Guggenheim |
Glenn Novarro | RBC Capital Markets |
David Lewis | Morgan Stanley |
Matthew O'Brien | Piper Jaffray |
Larry Biegelsen | Wells Fargo |
Richard Newitter | Leerink Partners |
Rick Wise | Stifel |
Isaac Ro | Goldman Sachs |
Robbie Marcus | JP Morgan |
Joanne Wuensch | BMO Capital Markets |
Vijay Kumar | Evercore ISI |
Raj Denhoy | Jefferies |
Craig Bijou | Cantor Fitzgerald |
Kyle Rose | Canaccord |
Jeff Johnson | Baird |
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Second Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, July 27, 2018. [Operator Instructions] I would now like to turn the conference over to Cole Lannum, Senior Vice President, Investor Relations and IRO. Please go ahead, sir.
Thank you, and good morning.